BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36347544)

  • 1. C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution.
    Li Y; Hou F; Zhou M; Yang X; Yin B; Jiang W; Xu H
    Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36347544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rampant C-to-U deamination accounts for the intrinsically high mutation rate in SARS-CoV-2 spike gene.
    Liu X; Liu X; Zhou J; Dong Y; Jiang W; Jiang W
    RNA; 2022 Jul; 28(7):917-926. PubMed ID: 35508354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence Supporting That C-to-U RNA Editing Is the Major Force That Drives SARS-CoV-2 Evolution.
    Wang J; Wu L; Pu X; Liu B; Cao M
    J Mol Evol; 2023 Apr; 91(2):214-224. PubMed ID: 36799984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The continuing discovery on the evidence for RNA editing in SARS-CoV-2.
    Pu X; Xu Q; Wang J; Liu B
    RNA Biol; 2023 Jan; 20(1):219-222. PubMed ID: 37199468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
    Simmonds P
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs.
    Li Y; Yang X; Wang N; Wang H; Yin B; Yang X; Jiang W
    Future Microbiol; 2020 Sep; 15():1343-1352. PubMed ID: 33085541
    [No Abstract]   [Full Text] [Related]  

  • 7. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
    Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
    PLoS One; 2020; 15(10):e0237689. PubMed ID: 33006981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.
    Ratcliff J; Simmonds P
    Virology; 2021 Apr; 556():62-72. PubMed ID: 33545556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.
    Kim K; Calabrese P; Wang S; Qin C; Rao Y; Feng P; Chen XS
    Sci Rep; 2022 Sep; 12(1):14972. PubMed ID: 36100631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
    Vlachogiannis NI; Verrou KM; Stellos K; Sfikakis PP; Paraskevis D
    Clin Immunol; 2021 May; 226():108699. PubMed ID: 33639276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-mutation modules capture the evolution and transmission patterns of SARS-CoV-2.
    Qin L; Ding X; Li Y; Chen Q; Meng J; Jiang T
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34121111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospect of the Two-Year Debate: What Fuels the Evolution of SARS-CoV-2: RNA Editing or Replication Error?
    Wei L
    Curr Microbiol; 2023 Mar; 80(5):151. PubMed ID: 36976379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2.
    Ringlander J; Fingal J; Kann H; Prakash K; Rydell G; Andersson M; Martner A; Lindh M; Horal P; Hellstrand K; Kann M
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35064076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic landscape of COVID-19: A South Asian perspective.
    Thomas V; Audsley J; Kapoor N
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S38-S43. PubMed ID: 32515376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational spectrum of SARS-CoV-2 during the global pandemic.
    Yi K; Kim SY; Bleazard T; Kim T; Youk J; Ju YS
    Exp Mol Med; 2021 Aug; 53(8):1229-1237. PubMed ID: 34453107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human SARS-CoV-2 has evolved to increase U content and reduce genome size.
    Wang Y; Chen XY; Yang L; Yao Q; Chen KP
    Int J Biol Macromol; 2022 Apr; 204():356-363. PubMed ID: 35149094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.
    Kockler ZW; Gordenin DA
    Cells; 2021 Jun; 10(6):. PubMed ID: 34202997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
    Koçhan N; Eskier D; Suner A; Karakülah G; Oktay Y
    Infect Genet Evol; 2021 Jul; 91():104796. PubMed ID: 33667722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-host mutation rate of acute SARS-CoV-2 infection during the initial pandemic wave.
    El-Haddad K; Adhikari TM; Tu ZJ; Cheng YW; Leng X; Zhang X; Rhoads D; Ko JS; Worley S; Li J; Rubin BP; Esper FP
    Virus Genes; 2023 Oct; 59(5):653-661. PubMed ID: 37310519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.
    Khattak S; Rauf MA; Zaman Q; Ali Y; Fatima S; Muhammad P; Li T; Khan HA; Khan AA; Ngowi EE; Wu DD; Ji XY
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.